Rapid-acting Treatments for Pediatric Depression and Suicidality: Where are We Now?
Brown University via Independent
-
119
-
- Write review
Master AI and Machine Learning: From Neural Networks to Applications
Earn a Michigan Engineering AI Certificate — Stay Ahead of the AI Revolution
Overview
Google, IBM & Meta Certificates – 40% Off
One plan covers every Professional Certificate on Coursera.
Unlock All Certificates
Jennifer B. Dwyer, MD, PhD
Co-Director Yale Pediatric Depression Program
Assistant Professor, Child Study Center and Dept of Radiology and Biomedical Imaging
Yale University
Syllabus
- Describe the proposed mechanism of action of novel rapid-acting anti-depressant and anti-suicidal pharmacotherapeutics
- Describe the state of the pediatric evidence base for rapid-acting treatments and to compare it with the adult evidence base
- Appreciate the unique developmental considerations that apply to testing and implementing novel therapeutics in the pediatric population